lifestyle.careersavvy.co.uk
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Lexaria Bioscience Corp.
Lexaria’s New Animal Study Aims to Expand Valuable Intellectual Property
April 15, 2026
Lexaria Applauds Eli Lilly’s Foundayo(TM) Drug Approval
April 7, 2026
Lexaria to Begin New Human Clinical Study in GLP-1
April 1, 2026
Lexaria’s Robust Patent Portfolio Continues to Grow
March 26, 2026
Lexaria Announces New R&D Plans for 2026
March 4, 2026
Lexaria Announces Positive Final Results From Human Pilot Study #5
February 7, 2026
Lexaria Awarded Six Additional Patents
January 22, 2026
Lexaria Releases Annual Letter from the CEO
January 12, 2026
Lexaria Releases Additional Results from its Successful Phase 1b Study GLP-1-H24-4
December 30, 2025
Primary Endpoint Successfully Achieved in Lexaria’s Phase 1b Study GLP-1-H24-4
December 23, 2025
1
2
Next Page
→